The Biosim•Exchange: Canada’s trusted source for timely information on biosimilars
As one of Canada’s leading patient voices, Arthritis Consumer Experts (ACE) has created a reader-friendly information hub for consumers and health care professionals to get the latest biosimilars news and background analysis through the Biosim•Exchange.
The Biosim•Exchange provides research-based information on biosimilar safety and effectiveness to inform consumers-patients (herein after referred to as patients) and report on public and private health insurance formulary policy or listing decisions.
Our aim with the development and timely delivery of biosimilars information is to help patients better understand biosimilars and their place among other inflammatory arthritis medications. Armed with this knowledge, patients and their physicians can build stronger partnerships leading to better health outcomes from their overall treatment plan.
ACE encourages you to share the Biosim•Exchange with other patients, your friends and family.
We look forward to your questions and comments and hearing about your experience with biosimilars.